-
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Источник: Buzz FX / 12 янв 2025 02:40:16 America/New_York
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 12, 2025 Share Link copied to clipboard. MoonLake Immunotherapeutics ( NASDAQ:MLTX - Get Free Report
Read more...